Law & Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law & Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Biotechnology Business

CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results

For the quarter ended December 31, 2007, the Company reported a net loss of $34.1 million, or $0.57 per share. This compares to a net loss of $68.1 million, or $1.18 per share, for the same quarter in 2006 and $34.2 million, or $0.58 per share, for the prior quarter ended September 30, 2007. For the year ended December 31, 2007, the Company reported a net loss of $181.0 million, or $3.05 per share, compared to a net loss of $274.3 million, or $5.49 per share, for the year ended December 31, 2006.

For the quarter ended December...

• View Other Issues of Law & Health Weekly
  
• View Other NewsRx Publications